Peakdale Molecular | News | Dr. Mick Durrant Appointed as Peakdale Molecular's Director of Business Development

Home Peakdale Home

About Us History Facilities Operational Board Non-Executive Directors Scientific Advisory Board

News and Events Latest News Archived News Events Peakdale Symposium

Products Intermediates New Products Screening Compounds

Services Contract Research Custom Synthesis Medicinal Chemistry Computational Chemistry Analytical ADMET Microwave Synthesis

Downloads New Products Intermediates Catalogue Screening/GPCR Catalogue Brochures

Recruitment Current Vacancies

Testimonials Client Testimonials

Responsibilities The Environment CSR

Collaborations Peakdale Collaborations

DR. MICK DURRANT APPOINTED AS PEAKDALE MOLECULAR'S DIRECTOR OF BUSINESS DEVELOPMENT

CHAPEL-EN-LE-FRITH, UK, 1st December 2009

Peakdale Molecular Ltd. a leading provider in specialist chemistry services to the pharmaceutical and biotechnology industry, today announces the appointment of Dr. Mick Durrant as its new Director of Business Development.

In his role, Mick will focus on building new business opportunities both nationally and internationally to add to Peakdale's rapidly expanding client base and enhanced products and services offering.

Mick brings over 20 years of industry experience to Peakdale. He most recently worked as Director of Business Development for Maybridge Ltd. where he was responsible for Business Development, Marketing and Sales within Europe and Asia.

Previously, Mick held the position of Managing Director of the UK division of the multinational pharmaceutical services provider, ASDI Biosciences Ltd. building $500K annual sales from for the company in 18 months from large and mid-size European pharmaceutical and biotechnology companies.

Prior to ASDI Mick had nine very successful years as Director of Business Development at Hickson International (a chemicals and custom synthesis company), and further developed his expertise at Ashwood Products (a pharmaceutical fine chemicals manufacturer) and Exxon Chemical Ltd. (Petrochemical industry).

Mick earned his undergraduate and postgraduate degrees from the University of Leicester, undertook post-doctoral studies at Oxford and holds an MBA from the University of Huddersfield.

"I am thrilled to be joining Peakdale at such a pivotal moment in the company's development. Peakdale's people assets and capabilities for customer driven chemistry projects are second to none in the industry" Mick Durrant commented.

Matt Tozer, Director of Medicinal Chemistry Services at Peakdale added "At such an exciting time in Peakdale's growth, I am delighted to have someone of Mick's calibre and experience as part of the team."

Peakdale Molecular - Latest News

DR. MICK DURRANT APPOINTED AS PEAKDALE MOLECULAR'S DIRECTOR OF BUSINESS DEVELOPMENT